Pharmacologic and pharmacokinetic characteristics of norgestimate and its metabolites
- 1 December 1990
- journal article
- review article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 163 (6) , 2127-2131
- https://doi.org/10.1016/0002-9378(90)90552-i
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Relative binding affinity of norgestimate and other progestins for human sex hormone-binding globulinSteroids, 1990
- The Selectivity of a New ProgestinActa Obstetricia et Gynecologica Scandinavica, 1990
- A comparison of the potencies and activities of progestogens used in contraceptivesContraception, 1987
- The affinity of norgestimate for uterine progestogen receptors and its direct action on the uterusContraception, 1985
- Oral contraceptives, lipids and cardiovascular diseaseContraception, 1985
- Reduced High-Density Lipoprotein-Cholesterol in Power Athletes: Use of Male Sex Hormone Derivates, an Atherogenic FactorInternational Journal of Sports Medicine, 1984
- Clinical Pharmacokinetics of Oral Contraceptive SteroidsClinical Pharmacokinetics, 1983
- SEX HORMONE BINDING GLOBULIN CAPACITY AS AN INDEX OF OESTROGENICITY OR ANDROGENICITY IN WOMEN ON ORAL CONTRACEPTIVE STEROIDSClinical Endocrinology, 1979
- Disposition of Norgestimate in the Presence and Absence of Ethinyl Estradiol after Oral Administration to HumansJournal of Pharmaceutical Sciences, 1978
- Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and ProgestinsNew England Journal of Medicine, 1978